Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CCB | SHBI |
|---|---|---|
| Price | $40.93 | $22.46 |
| Change today | ▲ 0.42% | ▼ 0.84% |
| Market cap | $625.67M | $749.54M |
| Return, 3 months | -47.9% | +0.8% |
| Return, year to date | -64.3% | +29.5% |
| Return, 1 year | -63.2% | +43.6% |
| P/E (TTM) | -146.2 | 11.4 |
| P/B | 1.4 | 1.2 |
| P/E percentile vs own 5y | 3rd | 41st |
| Dividend yield | – | 2.23% |
| Revenue growth (YoY, latest qtr) | +58.5% | +9.2% |
| Net profit growth (YoY) | -481.8% | +21.7% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | -0.8% | 27.9% |
| Return on equity | -0.8% | 11.2% |
| Analyst target vs. price | +22.2% | +13.5% |
| Analyst buy share | 100% | 33% |
| RSI (14) | 38 | 40 |
| 30-day volatility | 62.7% | 15.5% |
| Max drawdown, 1 year | -68.4% | -13.7% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
